-

Piper Sandler Expands Healthcare Investment Banking with Addition of Jeffrey Thomas

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Jeffrey Thomas as a managing director within the healthcare investment banking group. He will cover the MedTech and life science tools and diagnostics space and will be based in the firm’s Boston office.

Prior to joining the firm, Thomas served on Laborie’s leadership team as chief corporate development officer, where he was responsible for global strategy and M&A. Prior to that, he held executive roles in corporate development at Smith and Nephew and GE Healthcare. Thomas began his career in academic medical research and drug discovery roles at Joslin Diabetes Center | Harvard Medical School and Eli Lilly and Company, respectively, and with Banc of America Securities in its healthcare investment banking group.

“Jeff brings over 20 years of diverse experience in the healthcare industry – across R&D, deal execution and board advisory roles – and will be a great value-add to our investment banking platform,” said J.P. Peltier, global co-head of healthcare investment banking at Piper Sandler. “We look forward to welcoming Jeff to the team and continuing to deepen our footprint across the healthcare sectors.”

Thomas earned a bachelor’s degree in biochemistry from the University of Michigan and a Master of Business Administration from Kenan-Flagler Business School at the University of North Carolina.

ABOUT PIPER SANDLER

Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in Europe through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; and in Hong Kong through Piper Sandler Hong Kong Limited, authorized and regulated by the Securities and Futures Commission. Private equity strategies and fixed income advisory services are offered through separately registered advisory affiliates.

Follow Piper Sandler: LinkedIn | Facebook | Twitter

©2021. Since 1895. Piper Sandler Companies. 800 Nicollet Mall, Minneapolis, Minnesota 55402-7036

Contacts

Pamela Steensland
Tel: 612 303-8185
pamela.steensland@psc.com

Piper Sandler Companies

NYSE:PIPR

Release Summary
Piper Sandler Companies is pleased to announce the addition of Jeffrey Thomas as a managing director within the healthcare investment banking group.
Release Versions

Contacts

Pamela Steensland
Tel: 612 303-8185
pamela.steensland@psc.com

More News From Piper Sandler Companies

Piper Sandler Strengthens Fixed Income Platform with the Addition of Distressed Debt and Special Asset Group

NEW YORK--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the additions of John Mori and Eric Friel as managing directors to lead a new group that will focus on distressed debt and special assets. Mori will be based in Greenwich and Friel will be in New York, both reporting to Michael Piper, head of fixed income at Piper Sandler. The distressed debt and special asset group will source and trade specialized credit products, including distr...

Piper Sandler Companies Reports First Quarter 2026 Results; Increases Quarterly Dividend to $0.20 Per Share

MINNEAPOLIS--(BUSINESS WIRE)--The complete earnings release can be found on the firm's website at pipersandler.com/earnings...

Piper Sandler Strengthens Healthcare Investment Banking Team with the Addition of Patrick McCormack

MINNEAPOLIS & SAN FRANCISCO--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Patrick McCormack, M.D. as a managing director in the healthcare investment banking group. McCormack will be based in San Francisco and focused on advising biopharma companies on mergers and acquisitions and capital-raising transactions. “We are excited to welcome Patrick to the healthcare investment banking team. His deep expertise advising bioph...
Back to Newsroom